Nuformix (LSE:NFX)

UK company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - NFX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - NFX

  • Market Cap£18.220m
  • SymbolLSE:NFX
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINGB00BYW79Y38

Company Profile

Nuformix PLC is a pharmaceutical development company. It is focused on building value for shareholders through its activities in drug development and by out-licensing. The company uses cocrystal technology to re-engineer the crystalline form of known small molecule drugs. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.Nuformix PLC is a pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved drugs with lead programmes in oncology supportive care and fibrosis.

Latest NFX news

Currently there for this company. Visit our news hub for other news .

NFX Regulatory news

Currently there for this company. Visit our news hub for other news .